GSK and Other Companies Push Forward With RSV Vaccine Amid Shortages
The U.K. drugmaker GSK is seeking to expand regulatory approval for its new respiratory syncytial virus vaccine to include younger adults.
Stay updated with breaking news from Immunizations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.K. drugmaker GSK is seeking to expand regulatory approval for its new respiratory syncytial virus vaccine to include younger adults.
Moderna Inc. investors enjoyed a rare rally Tuesday as the shares of the biotechnology company headed for their first gain in two weeks.
By Josh Beckerman Moderna said the first participant has been dosed in a Phase 3 study of mRNA-1083, its combination vaccine candidate against influenza and...
Dozens of individuals referenced in a book co-published by RFK Jr.'s Children's Health Defense died of known causes not related to vaccines, including...
The single shot will cover the five most common serogroups that cause meningococcal disease in children and young adults.